Real World Evidence (RWE) - Data from Real Life

Due to comprehensive healthcare, digital data, individual social security number and progressive Biobank Act, Finland is the only country in the world, where systematic Real World Evidence -research is possible – we are thus a true model country for producing Real World Data.

Finnish biobanks are something completely unique; they are like an ocean of information, because they combine all the patient data that has been entered under the patient’s social security number in different data systems. This enables dynamic research use of the data.

At Medaffcon, we have wide ranging experience in utilising Real World Data, well-functioning cooperation with biobanks and a clear and proven process for research. When you need actual Real World Data, contact us!

Read more about our other services:

Stakeholder Perception Mapping | Medical Affairs | Market Access | Healthcare Consulting

Real World Evidence for your needs:

  • Our Scientific Experts ensure that your question is approached using the correct research methods and sources of information.

Entire process conducted with strong content understanding and expertise!

Why Work With Finland icon

Download Why Work With Finland? -presentation and find out what makes data collection in Finland unique.


Our RWE Experts:


 

Jarmo Hahl

Managing Director

Jarmo Hahl Medaffcon Market Access

Jarmo Hahl

Managing Director
M.Sc. (Economics)

+358 40 139 4001

LinkedIn

Jarmo joined Medaffcon as a Partner and Managing Director in 2010, after previously working in different positions in the pharmaceutical industry for eight years. Jarmo holds a comprehensive understanding of the pharmaceutical field: he has worked in several expert and leading positions, e.g. as a Health Economic Expert, Head of a Pricing and Reimbursement Unit and as a Director of Health Economics and Market Access teams. Before moving to the pharmaceutical industry, Jarmo had a permanent position in Turku School of Economics and he worked as a researcher at Turku University Hospital.

Due to his background, Jarmo has a strong knowledge of how new health technological innovations can meet the requirements and expectations of authorities, markets and customers. Medaffcon also benefits from his comprehensive experience in Health Economics and its applications from the perspective of research and commercialisation. In addition, he has wide-ranging understanding of the constantly changing operational environment.

Jarmo deems Market Access as multidisciplinary and crucial to business, which makes it an extremely interesting field of operation.

Jaana Ahlamaa

Director, Medical Affairs

Jaana Ahlamaa Medaffcon Medical Affairs

Jaana Ahlamaa

Director, Medical Affairs
MD (Specialist in Surgery), PhD

+358 50 5767 325

LinkedIn

Jaana began her career in the pharmaceutical industry as a Medical Advisor in different therapeutic areas, after which she became a Medical Affairs Manager. Jaana’s areas of responsibility have included, inter alia, sales permission, pharmacovigilance and marketing support functions. In 2006, Jaana became a Medical Director, assuming responsibility for all medical functions in the Finnish affiliate of the company she represented. After this, Jaana has worked in different Medical Advisor/Director positions in different companies.

Jaana established Medaffcon in 2009 after working in the pharmaceutical industry for almost ten years. Jaana’s most essential input in Medaffcon’s team is her wide-ranging experience and knowledge in different fields of the pharmaceutical industry, as well as the ability to think innovatively. Jaana’s key areas of interests include creating and maintaining cooperation between different activities and actors in the pharmaceutical industry. Jaana is also a member of the Board of the Finnish Association of Pharmaceutical Physicians.

Simo Jääskeläinen

Senior Market Access Manager

Simo Jääskeläinen Medaffcon Market Access

Simo Jääskeläinen

Senior Market Access Manager
M.Sc (Health Administration), BBA

+358 40 5800 567

LinkedIn

Simo rejoined Medaffcon’s team in June 2016 as a Senior Market Access Manager and Market Access team lead. In 2011, Simo was Medaffcon’s first recruited employee. Simo has 12 years of experience in the pharmaceutical industry, mostly in Market Access positions. In his early career, Simo also worked as a pharmaceutical Sales Representative. In addition to Medaffcon, Simo has worked, inter alia, at AstraZeneca, Abbott and Sanofi.

In the pharmaceutical industry, Simo is interested in the significance for the society and for the public health. Market Access functions are of interest to him particularly due to their diversity and varying situations. Market Access functions have a constantly increasing impact on business success, which is reflected in the fact that competition is moving from traditional marketing towards pricing and reimbursement processes.

Within Market Access functions, Simo’s strength is his wide-ranging expertise. He masters pricing and reimbursement processes and related tactics, but also the utilisation of health economics. As an employee, Simo is creative, reliable, systematic and diligent.

Iiro Toppila

Biostatistician

Iiro Toppila Medaffcon RWE

Iiro Toppila

Biostatistician
M.Sc. (Tech.)

+358 44 314 1597

Iiro joined Medaffcon in March 2017 as a Biostatistician. For the past four years he’s worked as a research assistant, analysing clinical and genetic patient data as part of a study on the factors impacting the appearance and progression of complications in type 1 diabetes (in FinnDiane research group). Iiro holds a Master of Science degree in Technology.

In the field, Iiro is particularly interested in the large data amounts revealed with the revolution of technology and in how the information received from the data can potentially be utilised to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment. Iiro’s strengths include his strong statistical expertise and the ability to understand the challenges and possibilities involved in “Big Data”.

Tanja Karvonen

Health Economist

Tanja Karvonen Medaffcon Market Access

Tanja Karvonen

Health Economist
M.Sc. (Health Economics & Economics)

+358 50 3286 651

LinkedIn

Tanja joined Medaffcon’s team in November 2016. She completed her MSc in Health Economics at the University of York and graduated in 2013. Tanja did her dissertation placement  at the University of Otago (Wellington, New Zealand). Previously, Tanja has also completed a Master’s degree in the field of Economics and Business Administration. Already during her previous degree, she acquainted herself with the methods of health economics, as she was writing her Master’s thesis under the supervision of a health economist at the University of Rennes (Rennes1, France) in 2010.

Tanja has gained her most recent work experience as a researcher at the National Institute for Health and Welfare. In addition, Tanja has experience in working in an international research group, in instructing course exercises in health economics as well as in working in financial administration and customer service.

Tanja would particularly like to utilise her educational and professional knowledge in health economics in her future work projects. Tanja thinks that there is need for health economics and its development in Finland, now in particular, as the social and healthcare system is under reform. It is necessary to be aware of how scarce resources are allocated at the level of both the society and an organisation. Tanja has a special interest in economic evaluation and comparison of processes in healthcare.

Tanja’s strengths include her educational and occupational background as well as her pursuit for constant improvement.  As an employee, Tanja is customer- and goal-oriented as well as reliable.

Maija Wolf

Scientific Advisor

Maija Wolf Medaffcon Medical Affairs

Maija Wolf

Scientific Advisor
PhD

+358 40 5720615

LinkedIn

Maija joined Medaffcon’s team in January 2017. She conducted her PhD studies at the University of Helsinki, after which she continued her studies as a postdoctoral researcher at the National Institutes of Health (NIH, Maryland, USA) and thereafter as a researcher at the VTT Medical Biotechnology and University of Turku. From 2008 onwards Maija has worked as a senior researcher at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, where she continues to work part-time.

Maija has a strong background in cancer biology and molecular medicine with emphasis on resolving how cancer evolves and identifying novel therapeutic opportunities. Maija has pedagogic and project leader skills and has already as a researcher worked as a project manager in several joint efforts with pharma industry. She is particularly enthusiastic about the potential of precision medicine and enjoys utilizing her experience from basic and translational research in tasks impacting human health.

Mariann Lassenius

Scientific Advisor

Mariann Lassenius Medaffcon Medical Affairs

Mariann Lassenius

Scientific Advisor
PhD

+358 50 3452 393

LinkedIn

Mariann joined Medaffcon’s Medical Team in June 2016.

Mariann holds a PhD in Science and has experience in medical research on diabetes and long-term complications at Folkhälsan Research Center and at the Nephrology Outpatient Clinic of the University of Helsinki.

Mariann has also gained experience in commercialising research innovations, after working as a part-time consultant at Biotech Start-Up Management.

Mariann completed her Master of Science degree at the Department of Biosciences of the University of Helsinki in 2007. She majored in Physiology and had Biochemistry as a minor.

In the field, Mariann is particularly interested in health-promoting changes enabled by digitalisation, both with regard to pharmaceutical companies and social services. Development of new medicinal products and  improvement of treatment provide the work with an extremely interesting dimension.

Mariann’s strengths at Medaffcon include her strong scientific expertise as well as the ability to analyse diverse health data in an appropriate manner and to work as a goal-oriented team player.